Company name: XLABS Therapeutics (ONT)
Description: Operator of a laboratory in Belleville, Ontario. The company’s laboratory focuses on extraction of cannabis into oil and research development purposes.
Industry: Healthcare | Group: Healthcare Services | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (no backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: Abattis Bioceuticals (CNQ: ATT) reached a definitive agreement to acquire 10% stake in the company for $2.5 million on June 27, 2018.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 19.07
Last known valuation date: 27-Jun-2018